₨ Official source-observed price
PKR 823.32
1 x 10's
PKR 82.33 / tablet
✓ Official DRAP price source observed · Source checked 2026-08-27
Price Intelligence
Equivalent price position
Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 82.33/ tablet
Price positionNear medianvs like-for-like peer median
Peer comparators139current-price listings
🔒
MedInfoBase Pharma Pro
View Price Intelligence PRO
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Rank & percentilePeer medianFull competitor listPortfolio intelligence
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Clarithromycin
- Therapeutic area
- Anti-infectives
- Drug class
- Macrolide antibacterials
- ATC
- J01FA
- Strength
- 500 mg
- Dosage form
- Tablet
- Pack
- 1 x 10's
- Registration no.
- 044156
- Price record verified
- 2026-08-11
- Latest DRAP source check
- 2026-08-27 02:56
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 823.32 | 2025-07-01 | 2026-08-11 | DRAP PharmaPrice Index | Current |
| PKR 798.23 | 2024-07-01 | 2026-08-11 | DRAP PharmaPrice Index | Historical |
Same generic
Other listed brands
Akric 250 mg/5 mLGenome Pharmaceuticals (Pvt.) Ltd. · PKR 759.96Akric 125 mg/5 mLGenome Pharmaceuticals (Pvt.) Ltd. · PKR 444.78Akric XL 500 mgGenome Pharmaceuticals (Pvt.) Ltd. · PKR 825.73Akric XL 500 mgGenome Pharmaceuticals (Pvt.) Ltd. · PKR 825.73Akric-250 250 mgGenome Pharmaceuticals (Pvt.) Ltd. · PKR 478.68Akric-500 500 mgGenome Pharmaceuticals (Pvt.) Ltd. · PKR 887.56APRO 500 mgPanacea Pharmaceuticals · PKR 919.06APRO 250 mgPanacea Pharmaceuticals · PKR 495.67
Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.
Cite this record
Medicine record · DRAP registration 044156MedInfoBase. (2026). Pyloclar 500 mg Tablet (1 x 10's), HIGH-Q Pharmaceuticals — registration and price record [Data set]. MedInfoBase. Retrieved September 18, 2026, from https://medinfobase.com/brand/pyloclar-500-mg-044156-1-x-10s-high-q-pharmaceuticals/ Data observed 11 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 044156.
MedInfoBase. Pyloclar 500 mg Tablet (1 x 10's), HIGH-Q Pharmaceuticals — registration and price record [Internet]. Islamabad: MedInfoBase; 2026 [cited 2026 Sep 18]. Available from: https://medinfobase.com/brand/pyloclar-500-mg-044156-1-x-10s-high-q-pharmaceuticals/ Data observed 11 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 044156.
MedInfoBase (2026) Pyloclar 500 mg Tablet (1 x 10's), HIGH-Q Pharmaceuticals — registration and price record. Available at: https://medinfobase.com/brand/pyloclar-500-mg-044156-1-x-10s-high-q-pharmaceuticals/ (Accessed: 18 September 2026).
"Pyloclar 500 mg Tablet (1 x 10's), HIGH-Q Pharmaceuticals — registration and price record." MedInfoBase, 2026, https://medinfobase.com/brand/pyloclar-500-mg-044156-1-x-10s-high-q-pharmaceuticals/. Accessed 18 Sep 2026.
MedInfoBase. 2026. "Pyloclar 500 mg Tablet (1 x 10's), HIGH-Q Pharmaceuticals — registration and price record." Accessed September 18, 2026. https://medinfobase.com/brand/pyloclar-500-mg-044156-1-x-10s-high-q-pharmaceuticals/.
Price and registration data on this page were observed on 11 August 2026. Records change over time, so please cite the observation date alongside the access date.